Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Lalonde

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Clinical Pharmacy|March 1, 1984
Correlation coefficient versus prediction error in assessing the accuracy of digoxin dosing methodsR L Lalonde, D Pao
Clinical Pharmacology and Therapeutics|October 23, 2008
Clinical pharmacology in the era of biotherapeuticsR L Lalonde, P Honig
Drug Intelligence & Clinical Pharmacy|July 1, 1982
Serum digoxin concentrations in atrial fibrillation: a reviewJ E Masuhara, R L Lalonde
Clinical Pharmacy|October 1, 1986
Digoxin-specific antibody fragments for the treatment of digoxin intoxicationB A Boucher, R L Lalonde
Clinical Pharmacology and Therapeutics|September 25, 2009
Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairmentR L Lalonde, J A Wagner
Clinical Pharmacology and Therapeutics|June 16, 2007
Introduction of quantitative methods in pharmacology and clinical pharmacology: a historical overviewA J Atkinson, R L Lalonde
Clinical Pharmacology and Therapeutics|November 18, 2011
Comparative efficacy and effectiveness: an opportunity for clinical pharmacologyR L Lalonde, R J Willke
Clinical Pharmacology and Therapeutics|December 23, 2006
Nontraditional approaches to first-in-human studies to increase efficiency of drug development: will microdose studies make a significant impact?R A Boyd, R L Lalonde
Pharmaceutical Research|June 1, 1996
Population pharmacokinetics of terfenadineR L Lalonde, D Lessard, J Gaudreault
Journal of Chromatography|June 14, 1991
Solid-phase extraction and direct high-performance liquid chromatographic determination of metoprolol enantiomers in plasmaV L Herring, T L Bastian, R L Lalonde
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Clinical Pharmacy|March 1, 1984
Correlation coefficient versus prediction error in assessing the accuracy of digoxin dosing methodsR L Lalonde, D Pao
Clinical Pharmacology and Therapeutics|October 23, 2008
Clinical pharmacology in the era of biotherapeuticsR L Lalonde, P Honig
Drug Intelligence & Clinical Pharmacy|July 1, 1982
Serum digoxin concentrations in atrial fibrillation: a reviewJ E Masuhara, R L Lalonde
Clinical Pharmacy|October 1, 1986
Digoxin-specific antibody fragments for the treatment of digoxin intoxicationB A Boucher, R L Lalonde
Clinical Pharmacology and Therapeutics|September 25, 2009
Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairmentR L Lalonde, J A Wagner
Clinical Pharmacology and Therapeutics|June 16, 2007
Introduction of quantitative methods in pharmacology and clinical pharmacology: a historical overviewA J Atkinson, R L Lalonde
Clinical Pharmacology and Therapeutics|November 18, 2011
Comparative efficacy and effectiveness: an opportunity for clinical pharmacologyR L Lalonde, R J Willke
Clinical Pharmacology and Therapeutics|December 23, 2006
Nontraditional approaches to first-in-human studies to increase efficiency of drug development: will microdose studies make a significant impact?R A Boyd, R L Lalonde
Pharmaceutical Research|June 1, 1996
Population pharmacokinetics of terfenadineR L Lalonde, D Lessard, J Gaudreault
Journal of Chromatography|June 14, 1991
Solid-phase extraction and direct high-performance liquid chromatographic determination of metoprolol enantiomers in plasmaV L Herring, T L Bastian, R L Lalonde
Pageof 5